Loading clinical trials...
Loading clinical trials...
It aims to determine and compare the degree of vaginal bacterial alpha diversity in the absence (healthy population) or presence of bacterial vaginosis (pathological population).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Larena SAS
Collaborators
NCT07199998 · Sexual Transmitted Disease, Vaginosis, Bacterial, and more
NCT03500107 · Vaginosis, Bacterial
NCT03943823 · Vaginosis, Vaginosis, Bacterial, and more
NCT05649735 · Vaginosis, Bacterial
NCT01322971 · Vaginosis, Bacterial, Infertility, and more
Institut FOURNIER
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions